Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA NegotiationsInvestors Business Daily • 08/15/24
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs MarketThe Motley Fool • 08/04/24
AstraZeneca falls after UK drug watchdog blocks NHS access to Enhertu drugProactive Investors • 07/30/24
Pharma companies less concerned after hearing from US on negotiated prices for MedicareReuters • 07/29/24
Govt body's procedures means people with cancer aren't getting drug - AstraZeneca bossSkynews • 07/25/24
Astrazeneca (AZN) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 07/25/24
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its OutlookInvestors Business Daily • 07/25/24